Consulting Services
For Investors
- Lucid Diligence Briefs
- Venture Capital Trends
Case Studies
Insights
- Conference Previews
- Conference Social Media Reports
LucidWargames
QuickAnswers
LucidSearch
BioPharma and Tech News

Contact Us

Search

Tessera Therapeutics

Respiratory

Respiratory Today—January 16, 2026

This week's respiratory update highlights continued momentum across pulmonary…

Respiratory

Respiratory Video Recap—December 12, 2025

This biweekly respiratory update covers regulatory milestones, late- and…

Rare Disease news

Rare Disease Video Recap—December 4, 2025

This biweekly Rare Disease Video Recap highlights regulatory designations,…

Cell_Gene_Therapy

Cell and Gene Therapy Today—December 4, 2025

This week’s Cell & Gene Therapy update highlights major gene-editing…

Categories

Obesity News
Endocrinology News
Our Insights
Immunology News
Case studies
Hematology News
BioPharma and Tech News
Oncology News
BioPharma Strategy, CI and AI Guides
Lucid Diligence Brief
Conference Social Media Reports
Venture Capital Trends
AI in Healthcare and Digital Health
Conference Previews
Cell and Gene Therapy News
Rare Disease News
Neuroscience News
Women's Health News
Public Health News
Respiratory News
Cardiovascular News
Vaccine news

Recent Posts

Lucid Diligence Brief: CORXEL $287m Series D1 for oral GLP-1 development
Lucid Diligence Brief: Mendra $82 million Series A to support AI-enabled rare-disease therapeutics
Respiratory Video Recap—January 23, 2026
Vaccines Video Recap—January 23, 2026
Public Health Today—23 January, 2026

Tags

Acella acquired hemophilia A amyloidosis antifungals BRAF V600 calcification-resistant tissue Capsida Biotherapeutics CD47 mAb Cirtuvivint Clinical AI scribes CORE-MD CT-388 dysferlinopathy Ebola Elicio Therapeutics GDNF Hypogammaglobulinemia IL-23 receptor INESSS Kyowa Kirin Lunit INSIGHT Merck KEYTRUDA mHSPC midomafetamine NRF2 NUHS Nuvation Bio OpenAI Patent litigation pay-per-inference pediatric cardiology PrEP quintuple agonist ROMVIMZA seltorexant SERD SLE Smart Inhaler Stevens-Johnson Syndrome TEER-ineligible Tezspire The Lancet Thyroid Artery Embolization Xinermei Zeposia

Archives

Archives

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

Lucid Diligence Brief: CORXEL $287m Series D1 for oral GLP-1 development
Lucid Diligence Brief: Mendra $82 million Series A to support AI-enabled rare-disease therapeutics
Respiratory Video Recap—January 23, 2026
Vaccines Video Recap—January 23, 2026
Public Health Today—23 January, 2026

TAGS

Acella acquired hemophilia A amyloidosis antifungals BRAF V600 calcification-resistant tissue Capsida Biotherapeutics CD47 mAb Cirtuvivint Clinical AI scribes CORE-MD CT-388 dysferlinopathy Ebola Elicio Therapeutics GDNF Hypogammaglobulinemia IL-23 receptor INESSS Kyowa Kirin Lunit INSIGHT Merck KEYTRUDA mHSPC midomafetamine NRF2 NUHS Nuvation Bio OpenAI Patent litigation pay-per-inference pediatric cardiology PrEP quintuple agonist ROMVIMZA seltorexant SERD SLE Smart Inhaler Stevens-Johnson Syndrome TEER-ineligible Tezspire The Lancet Thyroid Artery Embolization Xinermei Zeposia

Consulting Services
For Investors
- Lucid Diligence Briefs
- Venture Capital Trends
Case Studies
Insights
- Conference Previews
- Conference Social Media Reports
LucidWargames
QuickAnswers
LucidSearch
BioPharma and Tech News

© 2026 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy